MedTrace Logo

Motion Sickness Desensitization Using VR

NCT05628220 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-11-28

No results posted yet for this study

Summary

Evaluation of a virtual reality desensitization protocol on subjects with severe motion sickness and study of the role of the emotional component on the effectiveness of the therapy.

Conditions

Interventions

OTHER

physiotherapy

rehabilitation through using session of virtual reality desensitization

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • stephane BESNARD, Md,PhD · University Hospital, Caen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
67 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-10
Primary Completion
2023-02-28
Completion
2023-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05628220 on ClinicalTrials.gov